![James Schoeneck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Schoeneck
Presidente presso
KYNTRA BIO, INC.
Patrimonio netto: 289 330 $ in data 31/05/2026
Profilo
James A. Schoeneck è un uomo d'affari che è stato a capo di 5 diverse aziende. Attualmente, il sig. Schoeneck occupa la posizione di presidente di FibroGen, Inc. È anche nel consiglio di amministrazione di Calidi Biotherapeutics, Inc. Nella sua carriera passata James A. Schoeneck ha occupato la posizione di amministratore delegato di BrainCells, Inc., presidente, amministratore delegato e direttore di Assertio Therapeutics, Inc., amministratore delegato di ActivX Biosciences, Inc, Presidente, amministratore delegato e direttore operativo presso Prometheus Laboratories, Inc., vicepresidente e direttore generale di immunologia presso Centocor, Inc., direttore di KYORIN Pharmaceutical Co, Ltd. e direttore del gruppo marketing e prodotti presso Rhone-Poulenc Rorer, Inc. James A. Schoeneck si è laureato alla Jacksonville State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
KYNTRA BIO, INC. 0,98% | 12/06/2026 | 39.666 ( 0,98% ) | 273 695 $ | 31/05/2026 |
| 17/04/2026 | 84.514 ( 2,36% ) | 15 635 $ | 31/05/2026 |
Posizioni attive di James Schoeneck
| Società | Posizione | Inizio |
|---|---|---|
| KYNTRA BIO, INC. | Presidente | 06/01/2020 |
| CALIDI BIOTHERAPEUTICS, INC. | Presidente | 01/04/2025 |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Direttore/Membro del Consiglio | 22/07/2025 |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Direttore/Membro del Consiglio | 01/07/2020 |
Precedenti posizioni note di James Schoeneck
| Società | Posizione | Fine |
|---|---|---|
| ANAPTYSBIO, INC. | Direttore/Membro del Consiglio | 19/03/2018 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Amministratore Delegato | 28/03/2017 |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Amministratore Delegato | 01/01/2011 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Amministratore Delegato | 01/12/2004 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Amministratore Delegato | 01/01/2003 |
Formazione di James Schoeneck
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
60
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
KYORIN Pharmaceutical Co. Ltd. (old)
 KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Jacksonville State University
 Jacksonville State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
